Asia‐inclusive drug development leveraging principles of <scp>ICH E5</scp> and <scp>E17</scp> guidelines: Case studies illustrating quantitative clinical pharmacology as a foundational enabler
- DOI
- 10.1111/cts.70050
- Published
- 2024-10
- Container
- Clinical and Translational Science
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/cts.70050,
title = {Asia‐inclusive drug development leveraging principles of <scp>ICH E5</scp> and <scp>E17</scp> guidelines: Case studies illustrating quantitative clinical pharmacology as a foundational enabler},
author = {Hong Lu and Lena Klopp‐Schulze and Jatinder Kaur Mukker and Dandan Li and Yoshihiro Kuroki and Jayaprakasam Bolleddula and Nadia Terranova and Kosalaram Goteti and Wei Gao and Rainer Strotmann and Jennifer Dong and Karthik Venkatakrishnan},
year = {2024},
journal = {Clinical and Translational Science},
doi = {10.1111/cts.70050},
url = {https://doi.org/10.1111/cts.70050}
}RIS
TY - JOUR TI - Asia‐inclusive drug development leveraging principles of <scp>ICH E5</scp> and <scp>E17</scp> guidelines: Case studies illustrating quantitative clinical pharmacology as a foundational enabler AU - Hong Lu AU - Lena Klopp‐Schulze AU - Jatinder Kaur Mukker AU - Dandan Li AU - Yoshihiro Kuroki AU - Jayaprakasam Bolleddula AU - Nadia Terranova AU - Kosalaram Goteti AU - Wei Gao AU - Rainer Strotmann AU - Jennifer Dong AU - Karthik Venkatakrishnan PY - 2024 JO - Clinical and Translational Science DO - 10.1111/cts.70050 UR - https://doi.org/10.1111/cts.70050 ER -
APA
Lu, H., Klopp‐Schulze, L., Mukker, J. K., Li, D., Kuroki, Y., Bolleddula, J., Terranova, N., Goteti, K., Gao, W., Strotmann, R., Dong, J., & Venkatakrishnan, K. (2024). Asia‐inclusive drug development leveraging principles of <scp>ICH E5</scp> and <scp>E17</scp> guidelines: Case studies illustrating quantitative clinical pharmacology as a foundational enabler. Clinical and Translational Science. https://doi.org/10.1111/cts.70050
Source records
- crossref · retrieved 2026-09-24T21:40:59.144Z